focussed on the predominant Aβ peptides and their individual characterization. This work emphasizes on the behavior of various isoforms in mixtures, as to mimick the in vivo situation. The results indicate that subtle differences in the ratio of Aβ40 to Aβ42 can induces strong differences in aggregation behavior and toxicity. This observation is not limited to these isoforms: a small fraction of the shorter Aβ38 or the longer Aβ43 affects the aggregation behavior of the predominant Aβ isoforms. Additionally these minor peptides can enhance the toxic effects of Aβ40 on neurons while damping that of Aβ42. This is crucial for the development of new therapeutics as current strategies aim to decrease the production of Aβ42 while increasing Aβ38 levels at the same time. The strategy is based on the assumption that the presence of less aggregating Aβ38 is less hazardous than that of Aβ42.
The results presented here however suggest that the situation is more nuanced. A detailed understanding of the agggregation behavior of less predominant Aβ isoforms, in isolation but certainly in mixtures, will lead to better insight in the mechanisms leading to Alzheimer disease and as such contribute to improved therapeutic approaches. 
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